First Trust Advisors LP trimmed its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 19.0% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,436 shares of the company’s stock after selling 4,102 shares during the quarter. First Trust Advisors LP owned about 0.07% of USANA Health Sciences worth $1,006,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors also recently made changes to their positions in the company. BNP Paribas Arbitrage SA grew its holdings in USANA Health Sciences by 13.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 2,111 shares of the company’s stock worth $135,000 after buying an additional 245 shares in the last quarter. Victory Capital Management Inc. grew its holdings in USANA Health Sciences by 17.6% in the 2nd quarter. Victory Capital Management Inc. now owns 2,490 shares of the company’s stock worth $160,000 after buying an additional 373 shares in the last quarter. Creative Planning grew its holdings in USANA Health Sciences by 528.0% in the 2nd quarter. Creative Planning now owns 2,512 shares of the company’s stock worth $161,000 after buying an additional 2,112 shares in the last quarter. SG Americas Securities LLC bought a new position in USANA Health Sciences in the 2nd quarter worth approximately $162,000. Finally, Hikari Power Ltd bought a new position in USANA Health Sciences in the 2nd quarter worth approximately $221,000. Institutional investors and hedge funds own 43.82% of the company’s stock.
In other news, Director Myron W. Wentz sold 164,916 shares of the stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $66.40, for a total transaction of $10,950,422.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, major shareholder Global Ltd Gull sold 79,294 shares of the stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $57.61, for a total value of $4,568,127.34. Following the sale, the insider now owns 12,272,013 shares of the company’s stock, valued at approximately $706,990,668.93. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 806,060 shares of company stock valued at $51,895,822. 53.20% of the stock is currently owned by corporate insiders.
USNA has been the subject of a number of recent analyst reports. BidaskClub raised USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Thursday, October 26th. Pivotal Research increased their price target on USANA Health Sciences from $70.00 to $80.00 and gave the company a “buy” rating in a research note on Wednesday, October 25th.
Shares of USANA Health Sciences, Inc. (NYSE USNA) traded up $0.40 during midday trading on Tuesday, reaching $70.85. The company’s stock had a trading volume of 85,700 shares, compared to its average volume of 128,106. The company has a market cap of $1,690.28, a price-to-earnings ratio of 18.64 and a beta of 1.08. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $72.80.
USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 24th. The company reported $1.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.11. The firm had revenue of $261.77 million during the quarter, compared to analyst estimates of $259.52 million. USANA Health Sciences had a return on equity of 26.38% and a net margin of 8.79%. The firm’s quarterly revenue was up 3.0% on a year-over-year basis. During the same period last year, the company posted $2.40 EPS. equities research analysts forecast that USANA Health Sciences, Inc. will post 3.7 EPS for the current fiscal year.
WARNING: “First Trust Advisors LP Reduces Stake in USANA Health Sciences, Inc. (USNA)” was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this piece on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The original version of this piece can be viewed at https://www.dispatchtribunal.com/2017/12/05/first-trust-advisors-lp-reduces-stake-in-usana-health-sciences-inc-usna.html.
USANA Health Sciences Profile
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.